advisorsecurities master

QNRXQuoin Pharmaceuticals, Ltd. American Depositary Shares

ADRCNasdaq (XNAS)·USD

Identity

Security key
20651
Ticker
QNRX
Type
ADRCAmerican Depository Receipt Common
Exchange
Nasdaq(XNAS)
Venue group
NASDAQ
Operating MIC
XNAS
Market
stocks
Locale
us
Currency
USD
Listed
2021-10-28
Round lot
100
Active
Yes
Last seen in a load
2026-08-14 20:49
Vendor updated
2026-08-13 06:09
Ticker root / suffix
QNRX

Detail

Enriched 2026-08-14 20:47

Market cap
$11,829,582.02
Shares outstanding (class)
2,008,418
Shares outstanding (weighted)
2,008,418
SIC
2834 PHARMACEUTICAL PREPARATIONS
Employees
6
Location
KFAR SABA
Description

Quoin Pharmaceuticals Ltd is a clinical stage specialty pharmaceutical company focused on developing and commercializing therapeutic products that treat rare and orphan diseases. Its pipeline comprises three products that collectively have the potential to target a broad number of rare and orphan indications, including Netherton Syndrome, Peeling Skin Syndrome, Palmoplantar Keratoderma, Epidermolysis Bullosa, and others.

Market cap and share counts drift.

Funds holding this security

Identifiers

Classification

Fund data